BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15283158)

  • 1. [Telomerase activity in gastrointestinal, bladder and breast carcinomas and their clinical applications].
    Yoshida K; Toge T
    Nihon Rinsho; 2004 Jul; 62(7):1368-76. PubMed ID: 15283158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
    Yano Y; Yoshida K; Osaki A; Toge T; Tahara H; Ide T; Yasui W
    Anticancer Res; 2002; 22(6C):4101-7. PubMed ID: 12553039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
    Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H
    J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
    Shaker OG; Hammam O; Salehd A; el-Leithy T; Wishahi M
    Clin Biochem; 2009 Jun; 42(9):864-72. PubMed ID: 19272297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
    Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C
    Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
    Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
    Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].
    Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T
    Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
    Müller M; Krause H; Heicappell R; Tischendorf J; Shay JW; Miller K
    Clin Cancer Res; 1998 Aug; 4(8):1949-54. PubMed ID: 9717824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
    He GP; Shui QL; Huang Y; Zhang SZ; Yu H
    Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity is correlated with lower grade and lower stage bladder carcinomas.
    Okumura A; Mizuno I; Nagakawa O; Fuse H
    Int J Urol; 2004 Dec; 11(12):1082-6. PubMed ID: 15663679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
    Ito H; Kyo S; Kanaya T; Takakura M; Koshida K; Namiki M; Inoue M
    Clin Cancer Res; 1998 Nov; 4(11):2807-10. PubMed ID: 9829746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase in urological malignancy.
    Orlando C; Gelmini S; Selli C; Pazzagli M
    J Urol; 2001 Aug; 166(2):666-73. PubMed ID: 11458114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical implications of telomerase activity in breast cancer fine-needle aspirates].
    Jin S; Zhang W; Teng M
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):132-4. PubMed ID: 11776640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
    Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
    J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
    Tominaga T; Kashimura H; Suzuki K; Nakahara A; Tanaka N; Noguchi M; Itabashi M; Ohkawa J
    J Gastroenterol; 2002; 37(6):418-27. PubMed ID: 12108675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in human bladder cancer.
    Lin Y; Miyamoto H; Fujinami K; Uemura H; Hosaka M; Iwasaki Y; Kubota Y
    Clin Cancer Res; 1996 Jun; 2(6):929-32. PubMed ID: 9816252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
    Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
    J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.